arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Pennant Group, Inc.

PNTG
$39.70 ▲ +0.28 (+0.71%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
33 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Pennant Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.4B
Dividend Yield
Revenue Growth 35.8%
Op. Margin 5.8%
ROIC 6.6%
FCF / Share $0.44
Trailing P/E 152.7x
Price / Book
FCF Yield 1.1%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

33-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$297.98M
↑ +35.8%
Net Income Profit after all expenses
$8.52M
↑ +9.6%
Operating Margin Operating profit as % of sales
5.8%
↓ -4.9% 44th
FCF / Share Free cash flow per share
$0.44
↑ +278.0%
Long-Term Debt Long-term obligations
$192.50M
↑ +16.9%

Health Breakdown

Profitability
42
Financial Health
83
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 9 years · 33 quarters